Aidapak Recalls Acarbose Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling Acarbose 25 mg tablets because they may be mislabeled as Lactobacillus GG capsules.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation where use of the product may cause temporary or medically reversible health consequences. The hazard is a labeling error (mislabeling) rather than a contamination or structural defect, fitting the 'Moderate' criteria for minor labeling errors or low-risk issues.
Plain-English summary
Aidapak Services, LLC is recalling Acarbose, Tablet 25 mg, NDC 23155014701, due to a labeling error. The recall is classified as Class II by the U.S. Food and Drug Administration.
The specific issue is a label mixup where Acarbose tablets may be potentially mislabeled as Lactobacillus GG, Capsule, NDC 49100036374. The affected Acarbose tablets have the pedigree AD32757_1 and an expiration date of 5/13/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers and healthcare providers should check their inventory for Acarbose 25 mg tablets with the specified pedigree and expiration date. If found, these products should be returned to the distributor or disposed of according to local regulations. Patients should consult their healthcare provider for alternative treatment options if they have been prescribed this specific lot.
The recalled product
- Product
- ACARBOSE, Tablet 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 23155014701
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 100
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- ACARBOSE Tablet
- 25 mg has the following code Pedigree: AD32757_1
- EXP: 5/13/2014.
Distribution
Part of a larger recall action
This product is one of 273 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 273 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- SevereAidapak Recalls Acarbose Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateFDA Recalls Vitamin B Complex Capsules Due to Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Ascorbic Acid Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-29
- ModerateCarbidopa/Levodopa Tablets Recalled for Potential Label Mixup
FDA (Drugs) · 2014-01-29
- SevereAidapak Recalls Ascorbic Acid Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- HighAidapak Recalls Acyclovir Capsules Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-29